ABSTRACT-We investigated the antitumor effects of adriamycin (ADR)-loaded hydroxyapatite (HAP) beads in a Swarm rat chondrosarcoma model. When one ADR-loaded HAP bead (ADR: 0.8 mg/bead) was implanted into the central portion of a rat bearing tumor, the ADR-loaded HAP beads showed good therapeutic effects, increasing the life span (ILS) by 90010. Significantly, leukopenia and diarrhea were not observed. These results suggest that HAP delivery offers an interesting and a potentially effective method.
In general, initial applications included en bloc resec tion or local excision with curettage as the basic therapy of malignant bone tumors (1) . However, the possibility of remaining tumor cells persisted since surgery with curet tage is often difficult. Patients, therefore, had received sys temic postoperative adjuvant chemotherapy for controll ing local recurrence and metastasis to bone and lung (2) . Systemic administration of anticancer drugs may be in effective since chondrosarcoma, which comprises about 20% of all primary malignant bone tumors, shows low sensitivity to most anticancer drugs (3). Adriamycin (ADR) is an anthracycline antibiotic possessing antitumor activity against a variety of cancers (4) . Its systemic use, however, is limited by severe side effects that include dose-limiting myelosuppression and cardiotoxicity (5) . To reduce systemic toxicity while retaining or increasing the tumoricidal effect, the tumor should ideally be selec tively exposed to the anticancer drug. Therefore, it may be useful to fill the bony defect after excision with an active anticancer drug incorporated into hydroxyapatite (HAP) ceramics used in orthopedics as an aid in bone grafts for controlling local recurrence. On the other hand, to evaluate the therapeutic potential of anticancer drugs, it is important to use a selective tumor cell model. The Swarm rat chondrosarcoma was isolated from a tumor that originally arose spontaneously in an 18-month-old female Sprague-Dawley rat (6) . Its histological features such as moderate cellularity and mild nuclear hyper chromasia (7) are similar to those of well-differentiated
No references con cerning chemotherapy on a chondrosarcoma model with anticancer drug-loaded hydroxyapatite were observed. Therefore, we investigated the antitumor effects of ADR loaded HAP delivery using Swarm rat chondrosarcoma as an experimental chondrosarcoma.
ADR injection (Adriacin® 10 mg potency/vial) and ADR-HC1 were supplied by Kyowa Hakko Kogyo Co., Ltd., Tokyo. Porous HAP beads were a gift from NGK Spark Plug Co., Ltd., Nagoya. The physical data of the beads (XVC-56), given by the manufacture, are as fol lows: sintering temperature, 1100 C ; diameter, 8.48 mm; weight of one bead, 531 ±0.7 mg; bulk density, 1.66; true density of the material, 2.97; and Ca/P, 1.68. All other chemicals were of reagent grade. The drug amount loaded in the bead was estimated from the mean full displace ment of the pore spaces with water (0.140±0.001 ml, n=10). Preparation of the ADR-HAP beads (ADR: 0.8 mg/bead) was carried out as follows: HAP beads were placed in ADR aqueous solution (5.71 mg/ml) at 51C un der atmospheric pressure and allowed to remain for 1 hr. HAP beads containing drug solution were lightly wiped with a filter paper and lyophilized in a freeze-drying ap paratus (8) . Four-week-old male Sprague-Dawley (SD) rats weighing 90±5 g were obtained from Japan SLC, Ltd., Hamamatsu. In this study, the Swarm rat chon drosarcoma was maintained by subcutaneous transplanta tion into SD rats in our laboratory. When tumor cell sus pension (107 cells) was inoculated s.c. into four-week-old SD rats, the tumor size reached about _1.0 cm3 in 1 week postinoculation and --196 cm3 in 4 weeks. Tumor cell sus pensions (10' cells/ml) in 0.9% NaCI solution were pre pared by mincing tumor surgically obtained through a stainless steel sieve (pore size of 1-mm'). The tumor pieces were digested sequentially with 0.5% trypsin and 0.5% collagenase for about 90 min each. The concentration of cells released was determined by using a counter for bio cells (Elzone® Model 80). Tumor cell suspensions (1 ml) were inoculated s.c. into the armpit sites of SD rats on Day 0. All rats used in a single experiment (6 rats/group) were inoculated on the same day using cells from the same tumor. Rats were divided as follows: (i) Tumor growth of rats was determined by measuring the volumes with a caliper every 3 to 4 days postinoculation. Tumor volume was calculated by the formula 1/2ab2, where a is the long diameter and b is the short diameter (9). The antitumor effect was evaluated by comparing the mean survival time of the treated group (T) with that of the control group (C) and expressing it as an increase in life span (ILS).
The statistical significance of differences between ex perimental results was tested by Student's t-test. A P value of < 0.05 was considered significant.
The results of local ADR on this tumor system are shown in Table 1 .
The ADR-HAP beads showed higher tumor inhibition against Swarm rat chondrosarcoma compared with i.v. administration.
The ADR-HAP beads showed chemo therapeutic effects of 90% (P<0.05) ILS, and single i.v. injection showed effects of 66% ILS. No effect for tumor growth was observed in drug-free HAP beads compared with the untreated control. The changes in leukocyte counts are shown in Table 2 . Relative to the controls, the i.v. injected rats were leukopenic at 5 days after adminis tration (reduced to 46%, P < 0.05), while in rats implant ed with ADR-HAP beads, there was little change in the leu kocyte number (reduced to 94%). Neither administration produced significant changes in hemoglobin (data not shown). There is evidence that toxicity is more related to the peak serum levels of ADR cumulative dose (10) . In the present study, the ADR-loaded HAP delivery system showed higher antitumor effects but less systemic toxicity to an equal dose given by i.v. injection. These findings indicated that the use of ADR-loaded HAP delivery as a means of transporting anticancer agents is more effective in the delivery of high drug doses into the neoplasm with low serum levels than i.v. injection. In conclusion, this study suggests that the HAP drug delivery system offers an interesting and potentially effective method of anti cancer drug delivery with low systemic toxicity following local excision with the bony curettage of bone tumors. 
